Index of reports
> All Cases (5)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mustargen (Mechlorethamine) all cases. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Mustargen side effects in 42 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31
Patient: 42 year old female
Reactions: Atrial Septal Defect, Fatigue, Hypoxia, Breast Cancer in Situ, Fibrosis, Exercise Tolerance Decreased
Drug(s) suspected as cause:
Mustargen
Other drugs received by patient: Thyroid TAB; Lexapro (Escitalopram Ocalate); Calcium / Vitamin D (Lekovit CA); Levothyroxine Sodium
Possible Mustargen side effects in
Reported by a physician from Italy on 2012-05-11
Patient:
Reactions: Adverse Drug Reaction
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: Hodgkin's Disease
Vincristine
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Prednisone
Indication: Hodgkin's Disease
Doxorubicin HCL
Bleomycin Sulfate
Indication: Hodgkin's Disease
Mustargen
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Possible Mustargen side effects in
Reported by a physician from Italy on 2012-05-11
Patient:
Reactions: Chronic Lymphocytic Leukaemia
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: Hodgkin's Disease
Vincristine
Indication: Hodgkin's Disease
Prednisone
Indication: Hodgkin's Disease
Bleomycin Sulfate
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Doxorubicin HCL
Vinblastine Sulfate
Indication: Hodgkin's Disease
Mustargen
Indication: Hodgkin's Disease
Possible Mustargen side effects in 13 year old female
Reported by a physician from Italy on 2011-11-02
Patient: 13 year old female
Reactions: Mucosal Inflammation, Vomiting, Barrett's Oesophagus, Metaplasia, Oesophageal Stenosis
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: 6 courses
Indication: Hodgkin's Disease Stage III
Oncovin
Dosage: 6 courses
Indication: Hodgkin's Disease Stage III
Prednisone TAB
Dosage: 6 courses
Indication: Hodgkin's Disease Stage III
Vinblastine Sulfate
Dosage: 6 courses
Indication: Hodgkin's Disease Stage III
Dacarbazine
Dosage: 6 courses
Indication: Hodgkin's Disease Stage III
Procarbazine Hydrochloride
Dosage: 6 courses
Indication: Hodgkin's Disease Stage III
Adriamycin PFS
Dosage: 6 courses
Indication: Hodgkin's Disease Stage III
Mustargen
Dosage: 6 courses
Indication: Hodgkin's Disease Stage III
Possible Mustargen side effects in 40 year old male
Reported by a physician from Japan on 2011-10-06
Patient: 40 year old male
Reactions: Renal Disorder, Bone Marrow Failure, Mucous Membrane Disorder
Drug(s) suspected as cause:
Methotrexate Sodium
Indication: Immunodeficiency
Methotrexate
Indication: Hodgkin's Disease
Cyclosporine
Indication: Immunodeficiency
Prednisone
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Indication: Immunodeficiency
Procarbazine Hydrochloride
Indication: Hodgkin's Disease
Etoposide
Indication: Immunodeficiency
Mustargen
Indication: Diffuse Large B-Cell Lymphoma
Mustargen
Indication: Hodgkin's Disease
Adriamycin PFS
Indication: Hodgkin's Disease
Mustargen
Indication: Immunodeficiency
Methotrexate Sodium
Indication: Diffuse Large B-Cell Lymphoma
Cyclosporine
Indication: Hodgkin's Disease
Oncovin
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Indication: Immunodeficiency
Adriamycin PFS
Indication: Immunodeficiency
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Oncovin
Indication: Immunodeficiency
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Oncovin
Indication: Hodgkin's Disease
Adriamycin PFS
Indication: Diffuse Large B-Cell Lymphoma
Procarbazine Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Hodgkin's Disease
Prednisone
Indication: Diffuse Large B-Cell Lymphoma
|